Is Palindromic Rheumatism a Pre-rheumatoid Arthritis Condition? Low Incidence of Rheumatoid Arthritis in Palindromic Rheumatism Patients Treated with Tight Control Strategy.
Is Palindromic Rheumatism a Pre-rheumatoid Arthritis Condition? Low Incidence of Rheumatoid Arthritis in Palindromic Rheumatism Patients Treated with Tight Control Strategy.
نویسندگان: علیرضا خبازی اسکویی , نادره رشتچی زاده , مهرزاد حاج علیلوی بناب , آیدا مالک مهدوی , محمد میرزا آقازاده عطاری
کلمات کلیدی: Palindromic rheumatism, Rheumatoid arthritis, Disease-modifying anti-rheumatic drugs, Remission
نشریه: 29596 , 0 , 0 , 2019
| نویسنده ثبت کننده مقاله |
علیرضا خبازی اسکویی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
بیماری های بافت همبند |
| کد مقاله |
66847 |
| عنوان فارسی مقاله |
Is Palindromic Rheumatism a Pre-rheumatoid Arthritis Condition? Low Incidence of Rheumatoid Arthritis in Palindromic Rheumatism Patients Treated with Tight Control Strategy. |
| عنوان لاتین مقاله |
Is Palindromic Rheumatism a Pre-rheumatoid Arthritis Condition? Low Incidence of Rheumatoid Arthritis in Palindromic Rheumatism Patients Treated with Tight Control Strategy. |
| ناشر |
6 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Objectives: Palindromic rheumatism (PR) is characterized by repetitive, afebrile episodes of acute arthritis
and peri-arthritis. The aim of this study was considering the long-term outcomes of patients with PR who
were treated with tight control strategy using Disease-modifying anti-rheumatic drugs (DMARDs).
Methods: We reviewed the charts of 106 patients diagnosed with PR who were referred to the Connective
Tissue Diseases Research Center (CTDRC).We recruited all the patients diagnosed with PR according to the
criteria of Hannonen. They visited the CTDRC clinic regularly and were treated with hydroxychloroquine
and low dose prednisolone because of active episodes of PR. In cases that the attacks did not come
under control in 3–6 months, methotrexate was added or replaced and the dose was increased up to
25 mg/week. In resistant cases, sulfasalazine was added, followed by the addition of leflunomide and then
azathioprine. Disease outcome was evaluated by getting complete or partial remission and prevention
of disease evolution to rheumatoid arthritis (RA) or other inflammatory connective tissue diseases.
Results: This study included 92 patients with PR who were treated with DMARDs. Attacks were controlled
completely or partially in 76 (82.6%) patients. Medications free remission was obtained in 16.3% of the
patients. RA developed in 8.7% of the patients. By multivariate logistic regression analysis, age ≤40 at
disease presentation, non-adherence to therapy and PIP joints involvement were the only factors which
independently predicted the risk of treatment failure.
Conclusions: Tight control strategy by using DMARDs may control PR and prevent disease progression to
RA. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| Is Palindromic Rheumatism a Pre-rheumatoid Arthritis ConditionLow Incidence of Rheumatoid Arthritis in Palindromic Rheumatism Patients Treated with Tight Control Strategy.pdf | 1398/08/23 | 284999 | دانلود |